Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-01-02
Original market date: See footnote 1
1997-09-15
Product name:
BIO-MYCIN 200
Description:
CATTLE (INTRAMUSCULAR OR SUBCUTANEOUS), SWINE (INTRAMUSCULAR)
DIN:
02182890
Product Monograph/Veterinary Labelling:
Date:
2020-01-02
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
5180 South Service Road
Burlingtion
Ontario
Canada
L7L 5H4
Class:
Veterinary
Species:
Cattle , Swine (pigs)
Dosage form(s):
Solution
Route(s) of administration:
Subcutaneous , Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0105553001
| Active ingredient(s) | Strength |
|---|---|
| OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) | 200 MG / ML |